Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
SHZ: 301130.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- CEO
- Jun Zhang
- Employees
- 269
- Headquarters
- Panshi, China
- IPO year
- 2022
- Market cap
- CN¥2.5B
- Website
- https://xidianyy.com
Loading 301130…
Loading profile data…Frequently asked questions about 301130
What does Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (301130.SZ) do?
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sale of pharmaceutical products. The company offers drugs for the treatment of anemia, mental disorders, cardiovascular diseases, tumors, etc., as well as traditional Chinese medicines and raw materials. It provides drugs in...
Where does 301130.SZ trade?
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (301130.SZ) trades on the Shenzhen Stock Exchange.
What sector is 301130.SZ in?
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (301130.SZ) operates in the Basic Materials sector, specifically in the Chemicals industry.
Who is the CEO of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd?
Jun Zhang is the chief executive officer of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (301130.SZ).
Where is Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd headquartered?
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd is headquartered in China.
Does 301130.SZ pay a dividend?
Yes — Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (301130.SZ) paid a trailing twelve-month dividend of CNY 0.26 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 301130.SZ go public?
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (301130.SZ) completed its initial public offering in 2022.